Vascular Self-Expanding Stent System

Ideal for the Iliac: Epic Stent System
Ideal for the Iliac: Epic Stent System

Ideal for the Iliac: The Epic Stent is a self-expanding Nitinol stent designed to sustain vessel patency, while providing enhanced visibility and accuracy during placement.




Product Details


Epic Stent System provides exactly the right balance

Exceptional Flexibility
  • Tandem Architecture™ Stent Design features Macro™, Medium and Micro™ Struts, as well as patented connector patterns—designed to optimize flexibility
  • Hybrid Architecture Design with open- and closed-cell geometry engineered to provide flexibility and deployment uniformity
Balanced Radial Force
  • Macro and Micro Struts are engineered to work in tandem for balanced force—even in tortuous vasculature
Excellent Deployment Accuracy
  • Ergonomic handle with two convenient deployment options: thumb wheel and pull grip
  • Radiopaque stent markers and catheter shaft marker band enhance visibility and simplify placement
Fracture Resistance
  • Meticulous surface finishing and polishing to remove imperfections and improve fracture resistance
  • Tandem Architecture Stent Design engineered to bend and flex and reduce the risk of fracture
  • High-grade Nitinol tubing



Epic Vascular Self-Expanding Stent System Schematic



Product Specifications

Stent Diameters6 to 12 mm
Stent Lengths20, 30, 40, 60, 80, 100, 120 mm
Catheter Lengths75, 120 cm
Guide Wire System0.035" OTW
Introducer Sheath Compatibility6 F across all sizes
Catheter Nominal O.D.0.079" to 0.077" (distal to proximal)



Epic Stent Size Matrix

6 F Compatibility Across All Sizes
Length (mm)
Diameter (mm)
  20 30 40 60 80 100 120
Catheter lengths: 75 cm, 120 cm
Guidewire system: 0.035" OTW



ORION Clinical Information

A Boston Scientific Study of the Epic Self-Expanding Nitonol Stent System in the treatment of Atherosclerotic Lesions in Iliac Arteries



US IDE Clinical Trial to demonstrate similar patency across all TASC classifications



12-month Primary Patency by TASC Classification

chart:12-month primary patency at TASC classification


12-month data

  • 0% MI at 30 days (0/111)
  • 3.4% MAE at 9-months (4/117)
  • 0% MI in-hospital (0/111)
  • 5.4% TVR at 12-months (6/111)
  • 0% Amputation of index limb at 12-months (0/111)
12-month Primary data image


Composite Success Rates

Composite Success Rates image
  • 100% Technical Success
    (Per lesion) (166/166)
  • 99.2% Procedural Success
    (Per subject) (124/125)
  • 95.3% Late Clinical Success at 12 months
  • (Per subject) (101/106)



Tools and Resources